Respiratory · General Medicine
Aspiration Pneumonia & Pneumonitis
Also known as Aspiration pneumonia · Aspiration pneumonitis · Mendelson syndrome · Aspiration syndromes · Inhalation pneumonia
Aspiration pneumonitis is acute chemical lung injury after macroaspiration; aspiration pneumonia is infection in a host who aspirates. Distinguish the syndromes clinically, stabilise first, treat pneumonia according to CAP or HAP/VAP guidance, and reserve extra anaerobic therapy for abscess, empyema, or necrotising infection.
On this page & tools
Your progress
Saved locally on this device.
Practise this topic
Exam tags
Red flags
The core distinction
Aspiration is entry of material below the vocal cords. It may cause no illness, mechanical obstruction, chemical pneumonitis, bacterial pneumonia, or a combination. These syndromes overlap, so the diagnosis is a clinical synthesis rather than a single laboratory result or a rigid time cut-off.[1][3]
| Feature | Aspiration pneumonitis | Aspiration pneumonia |
|---|---|---|
| Primary process | Chemical alveolar injury from gastric contents | Infection after aspiration in a susceptible host |
| Typical context | Witnessed macroaspiration during anaesthesia, seizure, intoxication, vomiting, or markedly impaired consciousness | Dysphagia, weak cough, frailty, neurological disease, poor oral health, oesophageal disease, or recurrent silent aspiration |
| Tempo | Abrupt respiratory illness is typical | Usually evolving infective illness; the aspiration event is often not witnessed |
| Antibiotic decision | Supportive care if the picture is convincingly chemical and the patient improves | Start empiric antibiotics appropriate to the pneumonia setting and severity |
| Important caution | Fever, leukocytosis, and an early infiltrate can reflect inflammation rather than infection | No symptom, odour, lobe, or clock time proves infection or an anaerobic cause |
Why is 48 hours not a diagnostic switch?
The classic distinction remains useful, but “not better at 48 hours” is not a diagnostic test. Serial trajectory, new or persistent infective features, cultures when indicated, imaging, and alternative diagnoses determine whether antibiotics should be started, continued, narrowed, or stopped.[1][3][5]

Why aspiration causes disease
Airway protection depends on alertness, coordinated swallowing, glottic closure, cough, mucociliary clearance, and immune defence. Disease follows when the material is injurious, the inoculum overwhelms clearance, or these defences fail. Gastric contents can injure alveolar epithelium and endothelium, inactivate surfactant, increase permeability, and produce severe hypoxaemia or ARDS. Repeated aspiration of colonised secretions can seed pneumonia.[1][3]
Modern studies do not support teaching that routine aspiration pneumonia is predominantly anaerobic. The organisms usually reflect the acquisition setting and host: common CAP pathogens in community-onset disease, and a greater probability of resistant Gram-negative organisms or MRSA only when healthcare exposure and validated patient-specific risks support it. Anaerobes matter particularly when there is lung abscess, empyema, or necrotising infection.[2][5]

Risk factors and localisation
Look for the mechanism that failed:[1][5]
- Reduced consciousness: anaesthesia, seizures, sedative or alcohol intoxication, metabolic encephalopathy, or head injury.
- Oropharyngeal dysphagia: acute stroke, Parkinson disease, motor neurone disease, myasthenia, bulbar disease, frailty, or dementia.
- Weak cough or impaired clearance: neuromuscular weakness, tracheostomy, prolonged intubation, or critical illness.
- High oral bacterial burden: poor dentition, periodontal disease, xerostomia, and dependence for oral care.
- Oesophageal or gastric contributors: reflux, achalasia, diverticulum, obstruction, vomiting, or altered postoperative anatomy.
- Iatrogenic contributors: sedating medicines and feeding tubes. An NG or PEG tube does not abolish aspiration of secretions or refluxed material.
Gravity helps interpret imaging but does not prove aetiology. In a recumbent patient, posterior upper-lobe and superior lower-lobe segments are commonly dependent; in an upright patient, basal lower-lobe segments are commonly affected. Either lung may be involved, although right-sided disease is frequent.[1][3]

Clinical recognition
Features suggesting pneumonitis
A witnessed large-volume event followed by abrupt cough, wheeze, hypoxaemia, tachypnoea, or diffuse crackles favours chemical pneumonitis. Fever, leukocytosis, and radiographic opacities may occur from sterile inflammation, so none alone mandates antibiotics. Rapid improvement with supportive care supports the diagnosis retrospectively.[1][3]
Features suggesting pneumonia
A compatible host with fever or hypothermia, cough, purulent sputum, dyspnoea, pleuritic pain, delirium, systemic illness, and a new infiltrate favours pneumonia. Frail and immunocompromised patients may lack fever or cough. Foul sputum may raise concern for necrosis or abscess but is neither sensitive nor specific enough to make “anaerobic aspiration pneumonia” by itself.[1][5]
Bedside priorities
Assess airway protection, work of breathing, oxygenation, perfusion, conscious level, and sepsis. Then examine the mouth, dentition, neurological system, cough strength, voice after swallowing, and ability to manage secretions. Coughing with intake, a wet voice, food pocketing, or recurrent unexplained chest infection should trigger a structured swallow pathway; a gag reflex alone does not establish a safe swallow.[1]
Investigations
Choose tests for severity, microbiology, complications, and the cause of aspiration:[1][2][9]
- Chest radiograph confirms an infiltrate and may show collapse, cavitation, or an effusion. A normal early film does not override severe clinical illness.
- CT chest is appropriate when radiography is equivocal, disease is recurrent or non-resolving, or abscess, necrosis, empyema, obstruction, foreign material, or malignancy is suspected.
- Blood gas and routine blood tests are guided by physiological severity and comorbidity.
- Sputum and blood cultures are most useful in severe CAP, suspected MRSA or Pseudomonas, true HAP/VAP, immunocompromise, cavitating disease, or treatment failure. Obtain samples before antibiotics when this will not delay urgent treatment.
- Pleural ultrasound and diagnostic aspiration are required when pleural infection is suspected; send pleural fluid for chemistry, cell count, Gram stain, culture, and other locally indicated tests.
- VFSS or FEES defines the physiology of dysphagia and safe consistencies when a bedside screen is abnormal or uncertainty remains.
Immediate management
- Airway: position, clear visible material, suction the oropharynx, and intubate when airway protection or ventilation is failing. Do not perform blind finger sweeps.[1][3]
- Breathing: give oxygen for hypoxaemia and escalate respiratory support according to physiology. Severe aspiration-related ARDS requires critical-care management with a lung-protective ventilation strategy.[1]
- Circulation and sepsis: establish access, obtain appropriate cultures without delaying therapy, and manage shock using the local sepsis pathway.[2][9]
- Particulate aspiration: request urgent bronchoscopy when aspirated solid material is suspected to be causing central or lobar obstruction, persistent collapse, or failure of ventilation. Bronchoscopy does not reverse diffuse acid injury.[1][3]
- Antibiotic decision: withhold routine prophylactic antibiotics in a clear, uncomplicated chemical pneumonitis; start antibiotics promptly when bacterial pneumonia or sepsis is clinically suspected.[1][2]

Antibiotics: a source-correct framework
Community-onset disease
The 2019 ATS/IDSA CAP guideline retired the HCAP category. Nursing-home residence alone does not justify vancomycin, an antipseudomonal beta-lactam, or a carbapenem. Empiric MRSA or Pseudomonas aeruginosa coverage is reserved for locally validated risk factors—especially prior isolation of that organism and relevant recent hospitalisation with parenteral antibiotic exposure—and should be reviewed against cultures.[2]
True HAP or VAP
Pneumonia arising in a genuinely hospital-acquired or ventilator-associated setting follows HAP/VAP guidance, not a generic “aspiration” regimen. Use the unit antibiogram, severity, prior IV antibiotics, prior colonisation or infection, structural lung disease, and local resistance prevalence to decide whether antipseudomonal or MRSA coverage is required. Obtain respiratory cultures and de-escalate when results and clinical response permit.[9]
Duration and review
There is no universal 7–14-day aspiration course. For uncomplicated, improving CAP, the ATS/IDSA approach uses clinical stability and a minimum five-day course; HAP/VAP guidance also favours a short course with adjustment for response. Abscess, empyema, necrosis, unusual pathogens, inadequate source control, or immunocompromise may require longer specialist-directed treatment. Review antibiotics daily for route, spectrum, adverse effects, cultures, and stop date.[2][9]
Dysphagia and feeding decisions
A patient with an unsafe or uncertain swallow should not receive unsupervised food, drink, or oral medication while urgent assessment and an alternative hydration/medication plan are arranged. Speech and language therapy should define compensatory posture, supervision, texture, and rehabilitation; thickened fluids are not harmless and must be individualised because they can reduce intake and quality of life.[1]
In dysphagic acute stroke, the FOOD trial applies specifically to stroke: it did not support routine early PEG over nasogastric feeding. Use NG feeding initially when enteral nutrition is needed, reassess recovery, and make longer-term access decisions with the multidisciplinary team and patient or surrogate. Do not extrapolate the FOOD trial to dementia or other diseases.[6]
In severe dementia, feeding decisions require a separate goals-of-care and best-interest process. A Cochrane review found no eligible randomised trials and very low-certainty observational evidence; it found no evidence that tube feeding improves survival or quality of life and reported a signal for pressure-ulcer harm. Explain uncertainty honestly, consider careful assisted oral feeding where feasible, and recognise that a tube does not prevent aspiration of saliva or reflux.[10]
Complications and source control
Lung abscess or necrotising infection
Suspect these with persistent systemic illness, putrid sputum, haemoptysis, cavitation, or failure despite appropriate therapy. Obtain CT and microbiology, add reliable anaerobic coverage, and look for an obstructing tumour or foreign body. Duration is guided by clinical and radiological response rather than a fixed number of weeks. Bronchoscopy, percutaneous drainage, embolisation, or surgery is selected by respiratory, radiology, and thoracic teams according to obstruction, bleeding, source control, and response—not an isolated cavity-size threshold.[1][5]
Pleural infection or empyema
A new effusion, pleuritic pain, persistent fever, or sepsis should prompt pleural ultrasound and sampling. Frank pus or complicated infected fluid requires drainage plus antibiotics; loculation or failure requires early respiratory and thoracic surgical review. Do not delay source control while extending antibiotics alone.[1]
ARDS, sepsis, and recurrent aspiration
Severe chemical injury or pneumonia may progress to ARDS, shock, acute kidney injury, or death. Recurrent disease is a signal to re-examine swallow physiology, feeding supervision, oral health, sedation, reflux or oesophageal disease, seizures, and goals of care—not simply to repeat broader antibiotics.[1][5]
Treatment failure: ask six questions
Failure is lack of the expected clinical trajectory, deterioration at any time, or recurrent disease after apparent response—not a mandatory change at one clock time.[1][2]
- Is the patient unstable? Repeat ABC assessment and escalate care.
- Was the syndrome misclassified? Reconsider pneumonitis, pneumonia, obstruction, pulmonary oedema, bland or septic pulmonary embolism, organising pneumonia, haemorrhage, or ARDS.
- Is there a complication needing source control? Repeat radiography and use CT or pleural ultrasound for abscess, empyema, necrosis, collapse, or mass.
- Is microbiology missing? Obtain appropriate cultures; consider BAL for severe, immunocompromised, cavitating, or unexplained disease.
- Is treatment appropriate? Recheck acquisition setting, local resistance, prior isolates, dose adjustment, absorption, interactions, adherence, and de-escalation opportunities.
- Is aspiration continuing? Repeat swallow and feeding review; assess oral care, positioning, sedatives, oesophageal disease, and secretion management.[1][2]
Multiple bilateral or peripheral cavitating nodules should prompt consideration of septic pulmonary emboli rather than an aspiration abscess. Right-sided infective endocarditis is a classic source because infected venous emboli seed the pulmonary circulation; this mechanism requires endocarditis-directed investigation and treatment, not an aspiration label.[11]
Disposition, follow-up, and safety net
Discharge is appropriate only when respiratory and haemodynamic status are stable, oxygen needs are stable and manageable, mental state is safe for the planned setting, and hydration, medication, nutrition, and swallowing can be delivered without an unresolved aspiration hazard. Confirm that the patient or caregiver can implement the feeding-position, oral-care, and medication plan; arrange ownership of pending cultures, imaging, and swallow follow-up rather than leaving results unassigned.[1][2]
Give written return triggers for worsening breathlessness or oxygenation, recurrent choking or aspiration, fever, new confusion, inability to maintain hydration or nutrition, or failure to improve. Admit or escalate when physiology is unstable, airway protection is uncertain, oral or enteral delivery is unsafe, required support is unavailable, or an abscess, empyema, obstruction, or treatment failure still needs investigation or source control.[1][2]
Prevention: useful, but evidence-limited
Prevention is a tailored bundle: structured swallow assessment, supervised feeding, upright positioning during intake, individualised texture, rehabilitation, medication review, denture and dental care, assistance with regular oral hygiene, and management of the underlying neurological or oesophageal disorder. Feeding tubes and tracheostomy cuffs do not guarantee protection from aspiration.[1]
Does chlorhexidine prevent aspiration pneumonia?
Do not overclaim chlorhexidine. In nursing homes, the 2022 Cochrane review found insufficient evidence that professional oral care reduces pneumonia incidence, although it may reduce pneumonia-associated mortality; certainty was low. In ventilated adults, chlorhexidine oral care probably reduces VAP incidence but has little or no mortality or ventilation-duration benefit. Follow the local oral-care and VAP protocol rather than treating chlorhexidine as a universal aspiration-prevention measure.[7][8]
Regional and special-population boundaries
- Regional prescribing: use the current national or institutional CAP/HAP/VAP guideline and antibiogram. Drug availability, resistance, allergy pathways, and renal dosing differ; a global page should not prescribe a fixed regimen.[2][9]
- Acute stroke: screen swallowing before oral intake and use an immediate safe hydration, medication, and nutrition plan. The FOOD trial informs route decisions in stroke only.[6]
- Nursing-home resident: classify by clinical acquisition and validated resistant-pathogen risk. Residence alone is not HAP and does not mandate MRSA, antipseudomonal, or carbapenem therapy.[2]
- Intubated patient: apply VAP diagnostic and treatment principles, obtain respiratory cultures, and use local resistance data. Do not label all VAP “anaerobic aspiration.”[9]
- Immunocompromised patient: the differential includes opportunistic and non-infectious disease; involve the relevant specialist early, obtain targeted microbiology, and avoid relying on procalcitonin to exclude infection.[2]
- Pregnancy or anaesthesia: prevention and airway technique follow current anaesthetic guidance; if aspiration occurs, stabilise and distinguish chemical injury, obstruction, and infection. Do not use prophylactic antibiotics for uncomplicated pneumonitis.[1][3]
- Advanced dementia: use dementia-specific evidence and shared goals of care; do not cite the FOOD stroke trial as evidence for or against tube feeding in dementia.[6][10]
Exam pearls
- Pneumonitis is chemical; pneumonia is infective—but overlap is common and there is no precise 48-hour separator.[1][3]
- Routine aspiration pneumonia is treated as CAP or HAP/VAP; routine extra anaerobic coverage is not recommended.[2][5]
- Add anaerobic therapy for abscess, empyema, or necrotising infection.[2]
- Nursing-home residence is not automatic HAP; HCAP is retired.[2]
- A low procalcitonin neither distinguishes pneumonitis reliably nor justifies withholding initial CAP antibiotics.[2]
- Dependent segments support aspiration but do not prove it.[1]
- An intact gag does not certify safe swallowing; use a structured pathway and VFSS/FEES when indicated.[1]
- FOOD was a stroke trial, not a dementia trial.[6][10]
- Oral care is reasonable, but chlorhexidine is not a universal, mortality-improving prevention answer.[7][8]
- Failure demands re-imaging, microbiology, source-control review, diagnostic reconsideration, and renewed swallow assessment—not reflex broader antibiotics.[1][9]
References
- [1]Košutova P, Mikolka P. Aspiration syndromes and associated lung injury: incidence, pathophysiology and management. Physiol Res, 2021.PMID 35199544
- [2]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 2019.PMID 31573350
- [3]Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med, 2001.PMID 11228282
- [4]Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis, 2007.PMID 17278083
- [5]DiBardino DM, Wunderink RG. Aspiration pneumonia: a review of modern trends. J Crit Care, 2015.PMID 25129577
- [6]Dennis MS, Lewis SC, Warlow C. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet, 2005.PMID 15733717
- [7]Cao Y, Liu C, Lin J, et al. Oral care measures for preventing nursing home-acquired pneumonia. Cochrane Database Syst Rev, 2022.PMID 36383760
- [8]Zhao T, Wu X, Zhang Q, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev, 2020.PMID 33368159
- [9]Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis, 2016.PMID 27418577
- [10]Davies N, Barrado-Martín Y, Vickerstaff V, et al. Enteral tube feeding for people with severe dementia. Cochrane Database Syst Rev, 2021.PMID 34387363
- [11]Ye R, Zhao L, Wang C, Wu X, Yan H. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir Med, 2014.PMID 24183289